期刊文献+

柳氮磺胺吡啶联合甲氨蝶呤治疗类风湿关节炎的疗效观察 被引量:2

Efficacy observation of sulfasalazine combined with methotrexate in treatment of rheumatoid arthritis
暂未订购
导出
摘要 目的探讨类风湿关节炎的治疗方法。方法对50例类风湿关节炎患者给予柳氮磺吡啶、甲氨蝶呤联合治疗。甲氨蝶呤(MTX)7.5~15.0mg每周1次,柳氮磺胺吡啶(SSZ)1.0g口服3次/d。疗程为1年。结果显效42例,有效6例,无效2例,总有效率为96%。出现上腹不适、恶心等消化道反应5例,均能耐受,不需要中断治疗。无效2例,分别为白细胞减少和肝功能损害者,改用其他药物治疗,病情控制好。结论柳氮磺胺吡啶、甲氨蝶呤联合治疗类风湿关节炎缓解率较高,且副作用较小,药源广泛,价格低廉,是一种比较理想的方案。 Objective To investigate the treatment methods for rheumatoid arthritis. Methods Fifty patients with rheumatoid arthritis were treated with sulfasalazine and methotrexate combination therapy. 7.5-15.0 mg of methotrexate (MTX) was administrated once a week and 1.0 g of sulfasalazine (SSZ) was administrated orally 3 times a day. The treatment course was 1 year. Results Forty-two patients were markedly effective, 6 cases were effective and 2 cases were ineffective, with the total effective rate of 96%. Five patients had upper abdominal discomfort, nausea and other gastrointestinal reactions could tolerate the drugs and therefore did not require interruption of treatment. The two ineffective eases were leukopenia and hepatic dysfunction respectively, which were under good control after turning to other medications. Conclusion The sulfasalazine and methotrexate combination therapy has few side effects, extensive drug sources and low prices in the treatment of rheumatoid arthritis, thereby is an ideal solution.
作者 何春江
出处 《中国当代医药》 2013年第6期95-95,97,共2页 China Modern Medicine
关键词 类风湿关节炎 柳氮磺胺吡啶 甲氨蝶呤 疗效观察 Rheumatoid arthritis Sulfasalazine Methotrexate Efficacy observation
  • 相关文献

参考文献6

  • 1汪慧芸.瓜氨酸相关自身抗体在类风湿关节炎早期诊断的应用[J].右江医学,2009,37(6):650-652. 被引量:1
  • 2张俊霞.柳氮磺胺吡啶联合甲氨蝶呤治疗类风湿关节炎观察[J].现代中西医结合杂志,2011,20(26):3306-3306. 被引量:3
  • 3Lee HJ,Waller RD,Stebbings S. The effects of an orally administered probiotic on sulfasalazine metabolism in individuals with rheumatoid arthritis:a preliminary study[J].Int J Rheum Dis,2010,(01):48-54.
  • 4Hail N Jr,Chen P,Bushman LR. Teriflunomide (leflunomide) promotes cytostatic,antioxidant,and apoptotic effects in transformed prostate epithelial cells:evidence supporting a role for teriflunomide in prostate cancer chemoprevention[J].Neoplasia,2010,(06):464-475.
  • 5Gaujoux-Viala C,Smolen JS,Landewé R. Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs:a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis[J].Annals of the Rheumatic Diseases,2010,(06):1004-1009.
  • 6van der Leeden M,Dahmen R,Ursum J. Prediction of walking disability by disease-related factors in patients with rheumatoid arthritis[J].JOURNAL OF REHABILITATION MEDICINE,2010,(05):506-510.

二级参考文献9

  • 1李永哲.风湿免疫性疾病自身抗体检测的临床意义[J].辽宁医学杂志,2004,18(4):176-178. 被引量:13
  • 2梁一琳,刘小玲.抗角蛋白抗体对类风湿关节炎的诊断意义[J].海南医学,2005,16(1):49-49. 被引量:6
  • 3Berthelot JM, Maugars Y,Castagne A,et al. Antiperinuelear factors are present in polyarthritis before ACR criteria for rheumatoid arthritis are fulfilled[J]. Ann Rheum Dis, 1997,56:12.
  • 4Forslind K, Ahlmen M, Eberhardt K, et al. Prediction of radiologi cal outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP)[J]. Ann Rheum Dis, 2004,63 : 1090-1095.
  • 5Lindqvist E, Eberhardt K, Bendtzen K,et al. Prognostic laboratory markers of joint damage in rheumatoid arthritis [J]. Ann Rheum Dis,2005,64:196-201.
  • 6Vallbracht I, Rieber J,Oppermann M, et al. Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis[J]. Ann Rheum Dis, 2004,83 : 1079- 1084.
  • 7Vencovsky J,Machacek S, Sedova L, et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis[J]. Ann Rheum Dis, 2003,62 : 427- 430.
  • 8栗占国.风湿病[M].北京:中国中医药科技出版社,2003.
  • 9施桂英 栗占国.关节炎概要[M].北京:中国医药科技出版社,2001.327-348.

共引文献2

同被引文献17

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部